Identification of Biomarker Signatures and Candidate Drugs in Non-Small Cell Lung Cancer

Paper Details

Research Paper 01/01/2020
Views (484)
current_issue_feature_image
publication_file

Identification of Biomarker Signatures and Candidate Drugs in Non-Small Cell Lung Cancer

Md. Parvez Mosharaf, Amina Rownaq, S.M. Shahinul Islam, Md. Nurul Haque Mollah
Int. J. Biosci. 16(1), 107-119, January 2020.
Copyright Statement: Copyright 2020; The Author(s).
License: CC BY-NC 4.0

Abstract

Lung cancer is the most important health risk for human in worldwide. Non-small cell lung cancer (NSCLC) is the most common cause of premature death from malignant disease. The aim of the study was to determine the pathways and expression profile of the genes to discover molecular signature at RNA and protein levels which could serve as potential drug targets for therapeutics innovation and the identification of novel targets. Eight proteins, six TFs and seven miRNAs came into prominence as potential drug targets. The differential expression profiles of these reporter biomolecules were cross-validated by independent RNA-Seq and miRNA-Seq. Risk discrimination performance of the reporter biomolecules NPR3, JUN, PPARG, TP53, CKMT1A, SP3 and TFAP2A were also evaluated. Total 213 drugs and 7 proteins was found for non-small cell lung cancer through dgidb. Among these identified drugs seven drugs such as- Gemcitabine, Carboplatin, paclitaxel, Docetaxel, Crizotinib, Bevacizumab and Gemcitabine is used for NSCLC which is approved by National Cancer Institute. The molecular signatures and repurposed drugs presented here permit further attention for experimental studies which are offer significant potential as biomarkers and candidate therapeutics for precision medicine approaches to clinical management of NSCLC.

Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. 2013. Epidemiology of lung cancer: Diagnosis and management of lung cancer. Third Edition: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143, e1S, e29S.

Anaya J. 2016. OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Computer Science 2, e67.

Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall 1 KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Alexandra Soboleva A. 2013. NCBI GEO: Archive for functional genomics data sets – Update. Nucleic Acids Research 41, 991-995.

Bovolenta LA, Acencio ML, Lemke N. 2012. HTRIdb: An open-access database for experimentally verified human transcriptional regulation interactions. BMC Genomics 13, 405.

Calimlioglu B, Karagoz K, Sevimoglu T, Kilic E, Gov E, Arga KY. 2015. Tissue-Specific Molecular Biomarker Signatures of Type 2 Diabetes: An Integrative Analysis of Transcriptomics and Protein-Protein Interaction Data. OMICS 19, 563-573.

Chin C, Chen S, Wu H. 2009. Cyto-Hubba: A Cytoscape Plug-in for Hub Object Analysis in Network Biology. Genome Informatics 5, 2-3.

Chou CH, Chang NW, Shrestha S, Hsu SD, Lim YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, Tsai TR, Ho SY, Jian TY, Wu HY, Chen PR, Lin NC, Huang HT, Yang TL, Pai CY, Tai CS, Chen WL, Huang CY, Liu CC, Weng SL, Liao KW, Hsu WL, Huang HD. 2016. miRTarBase 2016: Updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Research 44, D239-D247.

Cotto KC, Wagner AH, Feng Y, Kiwala S, Coffman AC, Spies G, Wollam A, Spies NC, Griffith OL, Griffith M. 2017. DGIdb 3.0: a redesign and expansion of the drug–gene interaction database. Nucleic Acids Research 17.

D’Amico TA. 2008. Molecular biologic staging of lung cancer. The Annals of Thoracic Surgery 85, S737- S742.

Dzobo K, Senthebane DA, Rowe A, Thomford NE, Mwapagha LM, Al-Awwad N, Dandara C, Parker MI. 2016. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf. OMICS 20(12), 681-691.

Gentleman RC, Carey VJ and Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacas S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5, R80.

Gollapalli K, Ghantasala S, Atak A, Rapole S, Moiyadi A, Epari S, Srivastava S. 2017. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis. OMICS 21(5), 275-284.

Golub TR. 2001. Genome-wide views of cancer. The New England Journal of Medicine 344, 601–602.

Gov E, Kori M, Arga KY. 2017. Multiomics Analysis of Tumor Microenvironment Reveals Gata2 and miRNA-124-3p as Potential Novel Biomarkers in Ovarian Cancer. OMICS 21, 603-615.

Hu M, Qian C, Hu Z, Fei B, Zhou H. 2017. Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-α Correlates with Gastric Cancer Progression and Poor Prognosis. OMICS 21(1), 38-44.

Huang Z, Cheng Y, Chiu PM, Cheung FM, Nicholls JM, Kwong DL, Lee AW, Zabarovsky ER, Stanbridge EJ, Lung HL, Lung ML. 2012. Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties. Oncogene 31, 3709–3720.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics, CA: A Cancer Journal for Clinicians 57, 43-66.

Karagoz K, Sevimoglu T, Arga KY. 2016. Integration of multiple biological features yields high confidence human protein interactome. Journal of Theoretical Biology 403, 85-96.

Kori M, Gov E, Arga KY. 2016. Molecular signatures of ovarian diseases: Insights from network medicine perspective. Systems Biology in Reproductive Medicine 62, 266–282.

Lopez-Ayllon BD, Moncho-Amor V, Abarrategi A, Ibañez-de-Cáceres I, Castro-Carpeño J, Belda-Iniesta C, Perona R, Sastre L. 2014. Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations. Cancer Medicine 3(5), 1099-111.

Miskolczi Z, Smith MP, Rowling EJ, Ferguson J, Barriuso J, Wellbrock C. 2018. Collagen abundance controls phenotypes through lineage-specific microenvironment sensing. Oncogene. http://dx.doi.org/10.1038/s41388018-0209-0.

Patil KR, Nielsen J. 2005. Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proceedings of the National Academy of Sciences USA 102, 2685-2689.

Sevimoglu T, Arga KY. 2014. The role of protein interaction networks in systems biomedicine. Computational and Structural Biotechnology Journal 11, 22-27.

Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, Goodlett D, Berger JP, Gunter B, Linseley PS, Stoughton RB, Aebersold R, Collins SJ, Hanlon WA, Hood LE. 2004. Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Molecular & Cellular Proteomics 3(10), 960-969.

Turanli B, Arga KY. 2017. Systems biomedicine acts as a driver for the evolution of pharmacology. Annals of Pharmacology and Pharmaceutics 2, 1087.

Related Articles

Implications of aberrant glycosylation on age-related disease progression

Tahmid Ahmad Patwary, Mukramur Rahman, Md. Nafis Fuad Prottoy, Sayad Md. Didarul Alam, Int. J. Biosci. 27(2), 176-188, August 2025.

Design and development of solar powered water sprayer: A green technology innovation

Lorenzo V. Sugod, Int. J. Biosci. 27(2), 159-175, August 2025.

Knowledge, attitudes, practices, and social awareness regarding SARS-CoV-2 infection in the kyrgyz population in the post-pandemic period

Mirza Masroor Ali Beg, Haider Ali, Yahya Nur Ahmed, Yavuz Gunduz, Hafsa Develi, Tilekeeva UM, Int. J. Biosci. 27(2), 151-158, August 2025.

Tumor suppressing ability of myrtenal in DMBA-induced rat mammary cancer: A biochemical and histopathological evaluation

Manoharan Pethanasamy, Shanmugam M. Sivasankaran, Saravanan Surya, Raju Kowsalya, Int. J. Biosci. 27(2), 141-150, August 2025.

Assessing tree diversity in cashew plantations: Environmental and agronomic determinants in buffer zones of Mont Sangbé National Park, western Côte d’Ivoire

Kouamé Christophe Koffi, Kouakou Hilaire Bohoussou, Serge Cherry Piba, Naomie Ouffoue, Sylvestre Gagbe, Alex Beda, Adama Tondossama, Int. J. Biosci. 27(2), 122-133, August 2025.

Anthelmintic potential of powdered papaya seed Carica papaya in varying levels against Ascaridia galli in broiler chicken

Roniemay P. Sayson, Mylene G. Millapez, Zandro O. Perez, Int. J. Biosci. 27(2), 114-121, August 2025.

Valorization of fish scale waste for the synthesis of functional gelatin-based biopolymers

N. Natarajan Arun Nagendran, B. Balakrishnan Rajalakshmi, C. Chellapandi Balachandran, Jayabalan Viji, Int. J. Biosci. 27(2), 102-113, August 2025.